Key facts
- This page summarizes Novo Holdings A/S's Form 4 filing for MapLight Therapeutics, Inc. (MPLT).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 30 Oct 2025, 16:31.
Novo Holdings A/S - 28 Oct 2025 Form 4 Insider Report for MapLight Therapeutics, Inc. (MPLT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MPLT
- Reported as of
- 28 Oct 2025
- Net transaction value
- +$16,199,997
- SEC form
- 4
- Accepted by SEC
- 30 Oct 2025, 16:31:43 UTC
- Prior SEC filing
- 27 Oct 2025
- Next SEC filing
- 29 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Barbara Fiorini, General Counsel, Finance & Operations of Novo Holdings A/S
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Novo Holdings A/S filed Form 4 for MapLight Therapeutics, Inc. (MPLT) on 30 Oct 2025.
Change
- Previous filing in this sequence was filed on 27 Oct 2025.
- Current net transaction value: +$16,199,997.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001388325
Primary reporting owner
Novo Holdings A/S
- Relationship
- 10%+ Owner
- Address
- TUBORG HAVNEVEJ 19, HELLERUP, DENMARK
- Signature
- /s/ Barbara Fiorini, General Counsel, Finance & Operations of Novo Holdings A/S
- Signature date
- 30 Oct 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MPLT
transaction
Voting Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +2,733,681
- Change %
- Price
- Shares after
- 2,733,681
- Date
- 28 Oct 2025
- Ownership
- Direct
- Footnotes
- F1
MPLT
transaction
Voting Common Stock
Purchase
- Transaction value
- $16,199,997
- Shares
- +952,941
- Change %
- +35%
- Price
- $17.00
- Shares after
- 3,686,622
- Date
- 28 Oct 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MPLT
transaction
Derivative
Series C Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -26,191,207
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 28 Oct 2025
- Ownership
- Direct
- Underlying class
- Voting Common Stock
- Underlying amount
- 1,558,999
- Exercise price
- Footnotes
- F1
MPLT
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -19,734,671
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 28 Oct 2025
- Ownership
- Direct
- Underlying class
- Voting Common Stock
- Underlying amount
- 1,174,682
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Novo Holdings A/S is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Footnote F2
Represents a purchase from the underwriters in the Issuer's initial public offering.